• Home
  • Sichuan Duorui Biopharmaceutical Co., Ltd.
8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
G35
Book a meeting
25-27
Aug
2026
CPHI Korea 2026
COEX, Seoul, Korea
S31
Book a meeting
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
2K87
Book a meeting

Sichuan Duorui Biopharmaceutical Co., Ltd.

About Sichuan Duorui Biopharmaceutical Co., Ltd.

Sichuan Frontier Biopharmaceutical Co., Ltd. was established in 2018 and changed its name to Sichuan Duorui Pharmaceutical Co., Ltd. in 2024. Located in Chengdu-Aba Industrial Concentrated Development Zone, Jintang County, Chengdu City, Sichuan Province. It focuses on the R&D and production of peptides and Oligonucleotide APIs. The main products are Lanreotide Acetate, Semaglutide, Tirzepatide, Retatrutide Pegcetacoplan, and so on.

Read more Show less

Meet us at

  • CPHI South East Asia 2026

    CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Korea 2026

    CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026
  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2025
Contact info
  • 0354-6638277
  • No. 76 Jinle Road, Chengdu-Aba Industrial, Chengdu, China
Show contact info Hide contact info